Compare Snap Inc (SNAP) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Snap Inc vs GeneDx Holdings Corp — how do they compare? Snap Inc trades at $4.58 (market cap $7.67B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Snap Inc is far larger — about 4.3× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Snap Inc nearer its low. Which is the better fit depends on your goals.
| SNAP | WGS | |
|---|---|---|
Market Cap | $7.67B | $1.80B |
Sector | Media | Technology |
52-Week High | $10.35 | $167.51 |
52-Week Low | $3.93 | $34.51 |
Enterprise Value | $9.05B | $1.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Snap Inc. (SNAP) trades at $4.56, up 0.77% on the day, with a bearish technical signal and mixed fundamentals. Revenue grew to $5.93B in 2025, but net losses persist at -$460M. The stock shows improving cash flow from operations and has beaten EPS estimates in recent quarters. Analyst consensus is a 'Hold' with a $5.83 price target, suggesting modest upside from current levels.
The outlook remains cautious due to ongoing losses and competitive pressures, though cost-cutting and AR initiatives offer potential. Key risks include high debt, regulatory scrutiny, and uncertain demand for new products like SPECS glasses. Upside depends on sustained user engagement and profitability improvements.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
